Top Markets
Coin of the day
CSL Limited CSL Limited

CSL Limited

CSL
Rang in aandelen #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Aandeelprijs
$99.32
Marktkapitalisatie
$48.20B
Verandering (1 dag)
0.98%
Verandering (1 jaar)
-32.14%
Land
AU
Handel CSL Limited (CSL)

Categorie

Winst voor CSL Limited (CSL)
Winst in Dec 2025 TTM: $1.61B
Volgens de meest recente financiële verslagen van CSL Limited bedraagt de huidige winst van het bedrijf $1.61B. In 2024 behaalde het bedrijf een winst van $3.38B, een stijging ten opzichte van de winst van 2023, die $2.66B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van CSL Limited van 2000 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $1.61B -56.65%
2025 $3.72B 10.34%
2024 $3.38B 26.74%
2023 $2.66B -4.19%
2022 $2.78B -6.80%
2021 $2.98B 15.92%
2020 $2.57B 9.89%
2019 $2.34B 2.63%
2018 $2.28B 35.00%
2017 $1.69B 8.61%
2016 $1.56B -9.22%
2015 $1.71B 6.84%
2014 $1.60B 19.64%
2013 $1.34B 5.36%
2012 $1.27B -7.31%
2011 $1.37B 38.29%
2010 $992.87M 11.00%
2009 $894.45M 2.37%
2008 $873.74M 56.73%
2007 $557.47M 493.43%
2006 $93.94M -74.77%
2005 $372.39M 201.20%
2004 $123.64M 168.99%
2003 $45.96M -7.38%
2002 $49.63M -8.38%
2001 $54.17M 88.04%
2000 $28.81M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$20.51B 1,170.24%
DK
$4.64B 187.63%
US
$5.23B 224.03%
US
$2.14B 32.42%
BE
$1.45B -10.11%
NL